In this regard it welcomed the negotiations the UNAIDS Secretariat and Cosponsors are undertaking with the pharmaceutical industry to reduce antiretroviral (ARV) prices and that of drugs for the treatment of opportunistic infections. It encouraged UNAIDS to include a larger number of pharmaceutical companies in the negotiations, to extend the range of medicines and other relevant commodities for prevention and care to ensure a transparent process. The PCB welcomed the establishment of a contact group to be convened by the UNAIDS Secretariat and its Cosponsors, involving interested governments, selected on a regional/subregional basis, NGOs and donors with members of the PCB playing an important role. These negotiations should complement broader strategies to promote the sustainable access to drugs, such as the encouragement of local manufacturing and import practices consistent with national laws and internationa l agreements acceded to. It further encouraged UNAIDS to actively support countries in the development, implementation and financing of care strategies that enhance the overall effectiveness and sustainability of national responses to HIV/AIDS such as clinical guidelines, drug administrative and control management, diagnostic infrastructure and follow-up mechanisms.
- THE NGO DELEGATION
- PROGRAMME COORDINATING BOARD (PCB)